pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Celgene Corp

updated 3mo ago

Celgene Corporation is an American pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS) since its acquisition in 2019.

community read0 votes

🐶 often sniffed alongside

top 3
  • tagApproval12 co-mentions · 6 sources
  • drugluspatercept12 co-mentions · 6 sources
  • drugREBLOZYL12 co-mentions · 6 sources
pipeline
6
marketed
5
phase 3
0
catalysts ytd
1
approvals ytd
1
recalls ytd
0

Pipeline(6)

pipeline depth6 products
Marketed: 5Unknown: 1
5Marketed1Unknown
Marketed
POMALIDOMIDE
Kaposi Sarcoma
Marketed
idecabtagene vicleucel
Refractory Multiple Myeloma
Marketed
luspatercept
Anemia
Marketed
ozanimod hydrochloride
Ulcerative Colitis
Marketed
paclitaxel albumin bound
Non-Small Cell Lung Cancer
drug
REBLOZYL

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Celgene Corp jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Oncology4Breast Cancer1IBD (Crohn's + UC)1NSCLC1
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?